Jun-ichi Suzuki Selected Research

3- (3,4- dichlorobenzyl)- 5- (3,4,5- trihydroxybenzylidene)thiazolidine- 2,4- dione

7/2008

The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun-ichi Suzuki Research Topics

Disease

13	Myocarditis (Carditis) 04/2016 - 07/2003
10	Inflammation (Inflammations) 04/2012 - 11/2004
9	Myocardial Ischemia (Ischemic Heart Diseases) 12/2012 - 11/2003
7	Hyperplasia 07/2014 - 04/2004
6	Fibrosis (Cirrhosis) 07/2014 - 01/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 12/2012 - 08/2006
5	Reperfusion Injury 01/2011 - 11/2003
4	Ventricular Remodeling 07/2014 - 01/2006
4	Neointima 09/2013 - 01/2006
4	Thrombosis (Thrombus) 09/2013 - 07/2008
4	Vascular System Injuries 06/2008 - 04/2004
3	Heart Failure 11/2015 - 09/2006
3	Cardiomegaly (Heart Hypertrophy) 07/2014 - 08/2006
3	Heart Diseases (Heart Disease) 01/2011 - 06/2006
2	Myocardial Infarction 07/2014 - 12/2012
2	Infections 07/2014 - 12/2012
2	Hypertrophy 12/2012 - 08/2006
2	Infarction (Infarctions) 09/2010 - 11/2003
2	Ischemia 09/2010 - 02/2007
2	Atherosclerosis 01/2009 - 06/2005
2	Sleep Apnea Syndromes (Sleep Apnea) 03/2008 - 09/2006
2	Apnea 03/2008 - 09/2006
2	Sarcoidosis (Schaumann Disease) 06/2006 - 03/2003
1	Marfan Syndrome (Marfan's Syndrome) 01/2015
1	Pathologic Processes 07/2014
1	Hypoxia (Hypoxemia) 02/2014
1	Hemorrhage 01/2014
1	Vasculitis (Vasculitides) 02/2013
1	Neoplasms (Cancer) 03/2011
1	Arthritis (Polyarthritis) 03/2011
1	Asthma (Bronchial Asthma) 03/2011
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2011
1	Coronary Disease (Coronary Heart Disease) 10/2010
1	Hypertension (High Blood Pressure) 10/2010
1	Acute Coronary Syndrome 10/2010
1	Myocardial Reperfusion Injury 09/2010
1	Left Ventricular Dysfunction 09/2010
1	Arteriosclerosis 05/2010

Drug/Important Bio-Agent (IBA)

7	Matrix Metalloproteinases (MMPs)IBA 12/2012 - 02/2007
5	NF-kappa B (NF-kB)IBA 03/2011 - 12/2004
4	Proteins (Proteins, Gene)FDA Link 07/2014 - 08/2006
4	Cardiac MyosinsIBA 12/2013 - 07/2003
4	TeaIBA 01/2009 - 06/2005
3	Clarithromycin (Biaxin)FDA LinkGeneric 12/2012 - 04/2010
3	Plasminogen Activator Inhibitor 1IBA 01/2011 - 07/2008
3	Dinoprostone (PGE2)FDA Link 01/2011 - 01/2009
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2007 - 04/2005
2	PolyphenolsIBA 04/2016 - 01/2009
2	Transcription Factors (Transcription Factor)IBA 02/2014 - 07/2008
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2012 - 03/2003
2	CytokinesIBA 01/2011 - 04/2005
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2011 - 11/2008
2	Phenobarbital (Luminal)FDA Link 05/2010 - 06/2006
2	PPAR gammaIBA 05/2010 - 06/2006
2	NF-kappaB decoyIBA 07/2008 - 01/2006
2	Oxygen (Dioxygen)IBA 03/2008 - 09/2006
2	Fluvastatin FDA Link 08/2006 - 12/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2006 - 12/2004
2	Gallium-67IBA 06/2006 - 03/2003
1	NAD (NADH)IBA 11/2015
1	Extracellular Matrix ProteinsIBA 01/2015
1	Fibrillin-1IBA 01/2015
1	calpastatinIBA 07/2014
1	Cadherins (E-Cadherin)IBA 07/2014
1	CalpainIBA 07/2014
1	Cysteine Proteases (Cysteine Protease)IBA 07/2014
1	Monocyte Chemoattractant ProteinsIBA 07/2014
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 02/2014
1	Pharmaceutical PreparationsIBA 02/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014
1	cyclopropapyrroloindoleIBA 01/2014
1	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 09/2013
1	Interleukin-6 (Interleukin 6)IBA 09/2013
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2013
1	RetinoidsIBA 02/2013
1	Therapeutic UsesIBA 02/2013
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 02/2013
1	tamibaroteneIBA 02/2013
1	IMD-1041IBA 12/2012
1	MacrolidesIBA 12/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2012
1	CollagenIBA 01/2012
1	Plasminogen InactivatorsIBA 01/2011
1	ChemokinesIBA 01/2011
1	Fibrinolysin FDA Link 01/2011
1	Prostaglandins EIBA 01/2011
1	Immunoglobulin G (IgG)IBA 10/2010
1	SaltsIBA 10/2010
1	Telmisartan (Micardis)FDA Link 05/2010
1	N- (2,5- bis(trifluoromethyl)phenyl)- 5- bromo- 2- hydroxybenzamideIBA 12/2008

Therapy/Procedure

5	Heart Transplantation (Grafting, Heart) 01/2011 - 06/2004
3	Transplantation 05/2010 - 12/2006
3	Therapeutics 09/2006 - 04/2005
2	Percutaneous Coronary Intervention 09/2013 - 07/2008
2	Oral Administration 01/2009 - 02/2007
1	Intraperitoneal Injections 02/2013
1	Sutures (Suture) 01/2011
1	Stents 07/2008